Thyme Care raises $60M Series B funding for patient-centric cancer care platform

Thyme Care, a value-based cancer care platform, has secured $60 million in Series B funding led by Foresite Capital and Town Hall Ventures, with participation from existing investors.

Thyme Care collaborates with payers, employers, and providers to offer comprehensive services to individuals with cancer. 

Their tech-enabled care management platform connects patients with a care team of oncology professionals, provides information on diagnosis, symptom management, and offers resources for behavioural health, housing, transportation, and financial assistance. 

The funding will be used to expand their network of oncology partners and enhance their cancer care support services. David Whelan from Town Hall Ventures will join Thyme Care's board of directors.